Skip Navigation

JNCI Journal of the National Cancer Institute 2003 95(13):928-929; doi:10.1093/jnci/95.13.928
© 2003 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Longo, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Longo, D. L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 95, No. 13, 928-929, July 2, 2003
© 2003 Oxford University Press

EDITORIAL

Radiation Therapy in the Treatment of Hodgkin’s Disease—Do You See What I See?

Dan L. Longo

Correspondence to: Dan L. Longo, M.D., F.A.C.P., National Institute on Aging, Gerontology Research Center, Box 09, 5600 Nathan Shock Dr., Baltimore, MD 21224-6825 (e-mail: longod@grc.nia.nih.gov).

The first 150 words of the full text of this article appear below.

Science is simply common sense at its best—that is, rigidly accurate in observation, and merciless to fallacy in logic.

—Thomas H. Huxley

Controversy is an integral part of nearly all major progress in science and medicine. One exception is the development of an active therapy where no previous therapy was effective. A field generally has no problem adopting a novel active treatment. However, when newer approaches are found that are either safer or more effective or both, they sometimes have trouble displacing an established approach. And so it is with the role of radiation therapy in the treatment of Hodgkin’s disease.

Historically, radiation therapy was the first curative therapy for Hodgkin’s disease. Technical innovations in radiation equipment and clever designs of radiation fields brought us to the point where patients without B symptoms and with disease localized to one side of the diaphragm could have the Hodgkin’s disease permanently eradicated . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JCOHome page
J. Yahalom
Don't Throw Out the Baby With the Bathwater: On Optimizing Cure and Reducing Toxicity in Hodgkin's Lymphoma
J. Clin. Oncol., February 1, 2006; 24(4): 544 - 548.
[Full Text] [PDF]

Home page
 JCOHome page
P. Carde
The Chemotherapy/Radiation Balance in Advanced Hodgkin's Lymphoma: Overweight Which Side?
J. Clin. Oncol., December 20, 2005; 23(36): 9058 - 9062.
[Full Text] [PDF]

Home page
 Ann OncolHome page
A. Rueda Dominguez, A. Marquez, J. Guma, M. Llanos, J. Herrero, M. A. de las Nieves, J. Miramon, and E. Alba
Treatment of stage I and II Hodgkin's lymphoma with ABVD chemotherapy: results after 7 years of a prospective study
Ann. Onc., December 1, 2004; 15(12): 1798 - 1804.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
M. Bendandi, S. A. Pileri, and P. L. Zinzani
Challenging paradigms in lymphoma treatment
Ann. Onc., May 1, 2004; 15(5): 703 - 711.
[Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
B. M. P. Aleman, N. S. Russell, H. Bartelink, and F. E. van Leeuwen
Re: Radiation Therapy in the Treatment of Hodgkin's Disease--Do You See What I See?
J Natl Cancer Inst, February 4, 2004; 96(3): 235 - 236.
[Full Text] [PDF]

Home page
 JCOHome page
V. Diehl
Chemotherapy or Combined Modality Treatment: The Optimal Treatment for Hodgkin's Disease
J. Clin. Oncol., January 1, 2004; 22(1): 15 - 18.
[Full Text] [PDF]